How to buy Apollo Endosurgery stock (APEN)

Apollo Endosurgery is a healthcare equipment & supplies business based in the US. Apollo Endosurgery shares (APEN) are listed on the NASDAQ and all prices are listed in US Dollars.

Our top picks for where to buy Apollo Endosurgery stock

Buy Apollo Endosurgery stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Apollo Endosurgery stock price (NASDAQ: APEN)

Use our graph to track the performance of APEN stocks over time.

Apollo Endosurgery shares at a glance

• Key figures

Information last updated 2023-06-04.

52-week range	$0.00 - $0.00
50-day moving average more info button	$9.94
200-day moving average more info button	$7.73
Wall St. target price	$10.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-1.06

Is it a good time to buy Apollo Endosurgery stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Apollo Endosurgery financials

Revenue TTM	$76.9 million
Gross profit TTM	$42.4 million
Return on assets TTM	-14.39%
Return on equity TTM	-84.92%
Profit margin	-51.84%
Book value	$0.78
Market Capitalization more info button	$579.7 million

TTM: trailing 12 months

Apollo Endosurgery share dividends

We're not expecting Apollo Endosurgery to pay a dividend over the next 12 months.

Have Apollo Endosurgery's shares ever split?

Apollo Endosurgery's shares were split on a 1:5.5 basis on 29 December 2016 . So if you had owned 5.5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Apollo Endosurgery shares – just the quantity. However, indirectly, the new 450% higher share price could have impacted the market appetite for Apollo Endosurgery shares which in turn could have impacted Apollo Endosurgery's share price.

Apollo Endosurgery share price volatility

Over the last 12 months, Apollo Endosurgery's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Apollo Endosurgery's is 2.323. This would suggest that Apollo Endosurgery's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Apollo Endosurgery overview

Apollo Endosurgery, Inc. , a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc.

Frequently asked questions

null
What percentage of Apollo Endosurgery is owned by insiders or institutions?
Currently 4.288% of Apollo Endosurgery shares are held by insiders and 63.405% by institutions. When does the fiscal year end for Apollo Endosurgery?
Apollo Endosurgery's fiscal year ends in December. Where is Apollo Endosurgery based?
Apollo Endosurgery's address is: Building 1, Austin, TX, United States, 78746 What is Apollo Endosurgery's ISIN number?
Apollo Endosurgery's international securities identification number is: US03767D1081 What is Apollo Endosurgery's CUSIP number?
Apollo Endosurgery's Committee on Uniform Securities Identification Procedures number is: 548910108